secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001193125-24-182567
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor reports preliminary Q2 GAAP net loss $0.42-0.46/share, adj. EPS $0.32-$0.36; reaffirms FY guidance
--------------------------------------------------------------------------------

- Revenue $2,651-$2,671M; GAAP net loss per share $(0.42)-$(0.46); adjusted EPS $0.32-$0.36.
- One-time income tax charge of $17M ($0.22/share) from transfer pricing dispute; expected cash payment $30-$35M in H2 2024.
- Full-year 2024 outlook reaffirmed: revenue $10.5-$10.9B, adj. EBITDA $550-$590M, adj. EPS $1.40-$1.70.
- Adjusted EBITDA $123-$127M; operating cash flow $111-$116M; net debt reduction $68-$71M.
- Full Q2 results to be released on August 2, 2024, before NYSE open.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000119312524182567/0001193125-24-182567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000119312524182567/d857019d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-182567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer